Michael Gelband’s Microvast MVST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-167,824
Closed -$252K 1894
2026
Q1
$252K Sell
167,824
-136,209
-45% -$328K ﹤0.01% 1345
2025
Q4
$851K Buy
304,033
+242,131
+391% +$1.01M 0.01% 1049
2025
Q3
$238K Buy
+61,902
New +$193K ﹤0.01% 1347
2025
Q2
Sell
-74,278
Closed -$87K 1797
2025
Q1
$87K Buy
74,278
+36,685
+98% +$63.8K ﹤0.01% 1352
2024
Q4
$78K Buy
+37,593
New +$27.8K ﹤0.01% 1415
2023
Q3
Sell
-28,726
Closed -$46K 1983
2023
Q2
$46K Buy
+28,726
New +$41K ﹤0.01% 1778
2022
Q2
Sell
-474,597
Closed -$3.18M 2256
2022
Q1
$3.18M Buy
474,597
+327,774
+223% +$2.13M 0.04% 568
2021
Q4
$831K Buy
+146,823
New +$1.16M 0.01% 1168

Other funds holding MVST

Michael Gelband's MVST Position: Q2 2026 in Review

Michael Gelband sold out of Microvast (MVST) in Q2 2026, closing a stake of 167,824 shares — an estimated $252K sold.

Michael Gelband first reported a position in MVST in Q4 2021 and held it in 8 quarters. The position peaked at $3.18M in Q1 2022. 157 funds tracked by Wall St. Rank hold MVST as of Q2 2026.

  • Michael Gelband reported no remaining Microvast position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 167,824 Microvast shares in Q2 2026, an estimated $252K.
  • Michael Gelband first reported a position in Microvast in Q4 2021 and held it in 8 quarters.
  • Michael Gelband's Microvast position peaked at $3.18M in Q1 2022.
  • 157 funds tracked by Wall St. Rank held Microvast as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.